- Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
- Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
- Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
- Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
- Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
- Cerus Corporation to Participate in Upcoming Investor Conferences
More ▼
Key statistics
On Thursday, Cerus Corp (CU2:STU) closed at 1.53, 34.15% above the 52 week low of 1.14 set on Oct 19, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.52 |
---|---|
High | 1.53 |
Low | 1.52 |
Bid | 1.53 |
Offer | 1.56 |
Previous close | 1.53 |
Average volume | 0.00 |
---|---|
Shares outstanding | 181.28m |
Free float | 176.69m |
P/E (TTM) | -- |
Market cap | 297.30m USD |
EPS (TTM) | -0.2086 USD |
Data delayed at least 15 minutes, as of Apr 18 2024.
More ▼